Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

Journal of Infectious Diseases

Volumn 199, Issue 2, 2009, Pages 159-167

  Belongia, Edward A ^a   Kieke, Burney A ^a   Donahue, James G ^a   Greenlee, Robert T ^a   Balish, Amanda ^b   Foust, Angie ^b   Lindstrom, Stephen ^b   Shay, David K ^b  

^a MARSHFIELD CLINIC   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIGENICITY; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASON; VIRUS CULTURE; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEASONS; TREATMENT OUTCOME; VACCINES, INACTIVATED; WISCONSIN; YOUNG ADULT;

EID: 58849118576     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/595861     Document Type: Article

References (38)

1. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56:1-54.
2. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Wkly Epidemiol Rec 2005; 80:71-5.
3. Russell KL, Ryan MA, Hawksworth A, Freed NE, Irvine M, Daum LT. Effectiveness of the 2003-2004 influenza vaccine among US military basic trainees: a year of suboptimal match between vaccine and circulating strain. Vaccine 2005; 23:1981-5.
4. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001; 184:665-70.
5. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002; 35:370-7.
6. Centers for Disease Control and Prevention. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults - Colorado, 2003. MMWR 2004; 53:707-10.
7. Sugaya N, Nerome K, Ishida M, Matsumoto M, Mitamura K, Nirasawa M. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 1994; 272:1122-6.
8. Pyhala R, Haanpaa M, Kleemola M, Tervahauta R, Visakorpi R, Kinnunen L. Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match. Vaccine 2001; 19:3253-60.
9. DeStefano F, Eaker E, Broste S, et al. Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol 1996; 49:643-52.
10. Greenlee R. Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). Clin Med Res 2003; 1:273-80.
11. Greenlee R, Naleway AL, Vidaillet H. Incidence of myocardial infarction in a general population: the Marshfield Epidemiologic Study Area. WMJ 2002; 101:46-52.
12. Belongia EA, Chyou PH, Greenlee RT, Perez-Perez G, Bibb WF, DeVries EO. Diarrhea incidence and farm-related risk factors for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children. J Infect Dis 2003; 187:1460-8.
13. Centers for Disease Control and Prevention. Interim influenza vaccination recommendations, 2004-05 influenza season. MMWR Dispatch 2004; 53:1-2.
14. Centers for Disease Control and Prevention. Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season. MMWR Morb Mortal Wkly Rep 2005; 54:850.
15. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-42.
16. Sato M, Hosoya M, Kato K, Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005; 24:931-2.
17. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016-24.
18. Heikkinen T, Salmi AA, Ruuskanen O. Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. BMJ 2001; 322:138.
19. Heikkinen T, Marttila J, Salmi AA, Ruuskanen O. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol 2002; 40:4337-9.
20. Kendal AP, Pereira MS, Skehel JJ. Hemagglutination inhibition. In: Kendal AP, Pereira MS, Skehel JJ, eds. Concepts and procedures for laboratory-based influenza surveillance. Atlanta, GA: US Department of Health and Human Services and Pan-American Health Organization, 1982:B17-B35.9.
21. Pearce N. What does the odds-ratio estimate in a case-control study? Int J Epidemiol 1993; 22:1189-92.
22. Brookmeyer R, Liang KY, Linet M. Matched case-control designs and overmatched analyses. Am J Epidemiol 1986; 124:693-701.
23. Rothman K, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998.
24. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103:226-35.
25. Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.
26. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-5.
27. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333:889-93.
28. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999; 281:908-13.
29. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000; 284:1655-63.
30. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Jr., Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169:68-76.
31. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15:1114-22.
32. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22.
33. Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 1999; 17:82-94.
34. Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis 2008; 197:490-502.
35. Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25:2842-51.
36. Smith AB, Mock V, Melear R, Colarusso P, Willis DE. Rapid detection of influenza A and B viruses in clinical specimens by Light Cycler real time RT-PCR. J Clin Virol 2003; 28:51-8.
37. Zitterkopf NL, Leekha S, Espy MJ, Wood CM, Sampathkumar P, Smith TF. Relevance of influenza a virus detection by PCR, shell vial assay, and tube cell culture to rapid reporting procedures. J Clin Microbiol 2006; 44:3366-7.
38. Centers for Disease Control and Prevention. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine - Marshfield, Wisconsin, 2007-08 influenza season. MMWR 2008; 57:393-8.